The DOI matches its Crossref record; 172 of the 172 references it cites were found in a registry or an index.
Mechanisms and consequences of bacterial resistance to antimicrobial peptides
Open accessAbstract
Cationic antimicrobial peptides (AMPs) are an intrinsic part of the human innate immune system. Over 100 different human AMPs are known to exhibit broad-spectrum antibacterial activity. Because of the increased frequency of resistance to conventional antibiotics there is an interest in developing AMPs as an alternative antibacterial therapy. Several cationic peptides that are derivatives of AMPs from the human innate immune system are currently in clinical development. There are also ongoing clinical studies aimed at modulating the expression of AMPs to boost the human innate immune response. In this review we discuss the potential problems associated with these therapeutic approaches. There is considerable experimental data describing mechanisms by which bacteria can develop resistance to AMPs. As for any type of drug resistance, the rate by which AMP resistance would emerge and spread in a population of bacteria in a natural setting will be determined by a complex interplay of several different factors, including the mutation supply rate, the fitness of the resistant mutant at different AMP concentrations, and the strength of the selective pressure. Several studies have already shown that AMP-resistant bacterial mutants display broad cross-resistance to a variety of AMPs with different structures and modes of action. Therefore, routine clinical administration of AMPs to treat bacterial infections may select for resistant bacterial pathogens capable of better evading the innate immune system. The ramifications of therapeutic levels of exposure on the development of AMP resistance and bacterial pathogenesis are not yet understood. This is something that needs to be carefully studied and monitored if AMPs are used in clinical settings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
Liu, Y.-Y., Wang, Y., Walsh, T. R., Yi, L.-X., Zhang, R., Spencer, J., Doi, Y., Tian, G., Dong, B., Huang, X., et al. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00424-7 · Cited by 5,398
Mechanisms of Antimicrobial Peptide Action and Resistance
Yeaman, M. R., & Yount, N. Y. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.2 · Cited by 3,001
Jenssen, H., Hamill, P., & Hancock, R. E. W. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.00056-05 · Cited by 2,518
APD3: the antimicrobial peptide database as a tool for research and education
Wang, G., Li, X., & Wang, Z. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1278 · Cited by 2,388
Antibiotic resistance and its cost: is it possible to reverse resistance?
Andersson, D. I., & Hughes, D. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2319 · Cited by 2,294
Self-citationIsolation and characterization
Turksen, K. (2006) · Humana Press eBooks · Cited by 2,146
Falagas, M. E., Kasiakou, S. K., & Saravolatz, L. D. (2005) · Clinical Infectious Diseases · doi:10.1086/429323 · Cited by 1,744
Selection of Resistant Bacteria at Very Low Antibiotic Concentrations
Gullberg, E., Cao, S., Berg, O. G., Ilbäck, C., Sandegren, L., Hughes, D., & Andersson, D. I. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002158 · Cited by 1,654
Self-citationCutting Edge: 1,25-Dihydroxyvitamin D3 Is a Direct Inducer of Antimicrobial Peptide Gene Expression
Wang, T.-T., Nestel, F. P., Bourdeau, V., Nagai, Y., Wang, Q., Liao, J., Tavera-Mendoza, L., Lin, R., Hanrahan, J. W., Mader, S., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.5.2909 · Cited by 1,637
Symbiotic bacteria direct expression of an intestinal bactericidal lectin
Cash, H. L., Whitham, C. V., Behrendt, C. L., & Hooper, L. V. (2006) · Science · doi:10.1126/science.1127119 · Cited by 1,432
Defensins. Natural peptide antibiotics of human neutrophils.
Ganz, T., Selsted, M. E., Szklarek, D., Harwig, S. S., Daher, K., Bainton, D. F., & Lehrer, R. I. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112120 · Cited by 1,416
A peptide antibiotic from human skin
Harder, J., Bartels, J., Christophers, E., & Schröder, J.-M. (1997) · Nature · doi:10.1038/43088 · Cited by 1,363
Isolation and Characterization of Human μ-Defensin-3, a Novel Human Inducible Peptide Antibiotic
Harder, J., Bartels, J., Christophers, E., & Schröder, J.-M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008557200 · Cited by 1,311
AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense
Lai, Y., & Gallo, R. L. (2009) · Trends in Immunology · doi:10.1016/j.it.2008.12.003 · Cited by 1,276
Yang, D., Chen, Q., Schmidt, A. P., Anderson, G. M., Wang, J. M., Wooters, J., Oppenheim, J. J., & Chertov, O. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.7.1069 · Cited by 1,240
Innate antimicrobial peptide protects the skin from invasive bacterial infection
Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R. A., Pestonjamasp, V., Piraino, J., Huttner, K., & Gallo, R. L. (2001) · Nature · doi:10.1038/35106587 · Cited by 1,198
Bacterial membrane lipids: diversity in structures and pathways
Sohlenkamp, C., & Geiger, O. (2016) · FEMS Microbiology Reviews · doi:10.1093/femsre/fuv008 · Cited by 1,185
Wilson, C. L., Ouellette, A. J., Satchell, D. P., Ayabe, T., López-Boado, Y. S., Stratman, J. L., Hultgren, S. J., Matrisian, L. M., & Parks, W. C. (1999) · Science · doi:10.1126/science.286.5437.113 · Cited by 1,074
Antibacterial peptides for therapeutic use: obstacles and realistic outlook
MARR, A., GOODERHAM, W., & HANCOCK, R. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.04.006 · Cited by 1,051
Dendritic Cell Subsets and Lineages, and Their Functions in Innate and Adaptive Immunity
Liu, Y.-J. (2001) · Cell · doi:10.1016/s0092-8674(01)00456-1 · Cited by 1,004
Peschel, A., Otto, M., Jack, R. W., Kalbacher, H., Jung, G., & Götz, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8405 · Cited by 994
Wall Teichoic Acids of Gram-Positive Bacteria
Brown, S., Santa Maria, J. P., & Walker, S. (2013) · Annual Review of Microbiology · doi:10.1146/annurev-micro-092412-155620 · Cited by 966
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review
Zavascki, A. P., Goldani, L. Z., Li, J., & Nation, R. L. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm357 · Cited by 834
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies
Falagas, M. E., & Kasiakou, S. K. (2006) · Critical Care · doi:10.1186/cc3995 · Cited by 828
Moffatt, J. H., Harper, M., Harrison, P., Hale, J. D. F., Vinogradov, E., Seemann, T., Henry, R., Crane, B., St. Michael, F., Cox, A. D., et al. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00834-10 · Cited by 812
Peschel, A., Jack, R. W., Otto, M., Collins, L. V., Staubitz, P., Nicholson, G., Kalbacher, H., Nieuwenhuizen, W. F., Jung, G., Tarkowski, A., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.9.1067 · Cited by 786
Protection against enteric salmonellosis in transgenic mice expressing a human intestinal defensin
Salzman, N. H., Ghosh, D., Huttner, K. M., Paterson, Y., & Bevins, C. L. (2003) · Nature · doi:10.1038/nature01520 · Cited by 765
Zanetti, M., Gennaro, R., & Romeo, D. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01050-o · Cited by 713
Antimicrobial peptides: linking partition, activity and high membrane-bound concentrations
Melo, M. N., Ferre, R., & Castanho, M. A. R. B. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2095 · Cited by 709
Role of lipids in the interaction of antimicrobial peptides with membranes
Teixeira, V., Feio, M. J., & Bastos, M. (2012) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.12.005 · Cited by 692
Molecular mechanisms of membrane targeting antibiotics
Epand, R. M., Walker, C., Epand, R. F., & Magarvey, N. A. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.10.018 · Cited by 666
Defensins of vertebrate animals
Lehrer, R. I., & Ganz, T. (2002) · Current Opinion in Immunology · doi:10.1016/s0952-7915(01)00303-x · Cited by 662
Gunn, J. S., Lim, K. B., Krueger, J., Kim, K., Guo, L., Hackett, M., & Miller, S. I. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00757.x · Cited by 655
Lipid A Acylation and Bacterial Resistance against Vertebrate Antimicrobial Peptides
Guo, L., Lim, K. B., Poduje, C. M., Daniel, M., Gunn, J. S., Hackett, M., & Miller, S. I. (1998) · Cell · doi:10.1016/s0092-8674(00)81750-x · Cited by 649
Production of β-defensins by human airway epithelia
Singh, P. K., Jia, H. P., Wiles, K., Hesselberth, J., Liu, L., Conway, B.-A. D., Greenberg, E. P., Valore, E. V., Welsh, M. J., Ganz, T., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14961 · Cited by 579
Gudmundsson, G. H., Agerberth, B., Odeberg, J., Bergman, T., Olsson, B., & Salcedo, R. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.0325z.x · Cited by 578
Yang, D., Biragyn, A., Hoover, D. M., Lubkowski, J., & Oppenheim, J. J. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104603 · Cited by 572
Landman, D., Georgescu, C., Martin, D. A., & Quale, J. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00006-08 · Cited by 565
Indolicidin, a novel bactericidal tridecapeptide amide from neutrophils.
Selsted, M. E., Novotny, M. J., Morris, W. L., Tang, Y. Q., Smith, W., & Cullor, J. S. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42830-x · Cited by 546
hBD‐1: a novel β‐defensin from human plasma
Bensch, K. W., Raida, M., Mägert, H.-J., Schulz-Knappe, P., & Forssmann, W.-G. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00687-5 · Cited by 545
A Salmonella Locus that Controls Resistance to Microbicidal Proteins from Phagocytic Cells
Fields, P. I., Groisman, E. A., & Heffron, F. (1989) · Science · doi:10.1126/science.2646710 · Cited by 540
Primary structures of three human neutrophil defensins.
Selsted, M. E., Harwig, S. S., Ganz, T., Schilling, J. W., & Lehrer, R. I. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112121 · Cited by 534
Human Antimicrobial Peptides and Proteins
Wang, G. (2014) · Pharmaceuticals · doi:10.3390/ph7050545 · Cited by 528
Mechanism of Lipid Bilayer Disruption by the Human Antimicrobial Peptide, LL-37
Henzler Wildman, K. A., Lee, D.-K., & Ramamoorthy, A. (2003) · Biochemistry · doi:10.1021/bi0273563 · Cited by 518
Agerberth, B., Gunne, H., Odeberg, J., Kogner, P., Boman, H. G., & Gudmundsson, G. H. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.1.195 · Cited by 503
Monocyte-chemotactic activity of defensins from human neutrophils.
Territo, M. C., Ganz, T., Selsted, M. E., & Lehrer, R. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114394 · Cited by 489
Wang, G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805533200 · Cited by 482
Mechanism of antimicrobial action of indolicidin
Subbalakshmi, C. (1998) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(98)00008-1 · Cited by 474
García, J.-R. C., Krause, A., Schulz, S., Rodríguez-Jiménez, F.-J., Klüver, E., Adermann, K., Forssmann, U., Frimpong-Boateng, A., Bals, R., & Forssmann, W.-G. (2001) · The FASEB Journal · doi:10.1096/fj.00-0865fje · Cited by 470
Adams, M. D., Nickel, G. C., Bajaksouzian, S., Lavender, H., Murthy, A. R., Jacobs, M. R., & Bonomo, R. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00284-09 · Cited by 448
Imamovic, L., & Sommer, M. O. A. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006609 · Cited by 444
McPhee, J. B., Lewenza, S., & Hancock, R. E. W. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03673.x · Cited by 443
Persistence of antibiotic resistance in bacterial populations
Andersson, D. I., & Hughes, D. (2011) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2011.00289.x · Cited by 435
Self-citationGallo, R. L., Kim, K. J., Bernfield, M., Kozak, C. A., Zanetti, M., Merluzzi, L., & Gennaro, R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.20.13088 · Cited by 419
García, J.-R., Jaumann, F., Schulz, S., Krause, A., Rodríguez-Jiménez, J., Forssmann, U., Adermann, K., Klüver, E., Vogelmeier, C., Becker, D., et al. (2001) · Cell and Tissue Research · doi:10.1007/s004410100433 · Cited by 410
Gunn, J. S., & Miller, S. I. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.23.6857-6864.1996 · Cited by 409
Nonproteinogenic Amino Acid Building Blocks for Nonribosomal Peptide and Hybrid Polyketide Scaffolds
Walsh, C. T., O'Brien, R. V., & Khosla, C. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201208344 · Cited by 406
A cathelicidin family of human antibacterial peptide LL‐37 induces mast cell chemotaxis
Niyonsaba, F., Iwabuchi, K., Someya, A., Hirata, M., Matsuda, H., Ogawa, H., & Nagaoka, I. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01398.x · Cited by 402
Gunn, J. S., Ryan, S. S., van Velkinburgh, J. C., Ernst, R. K., & Miller, S. I. (2000) · Infection and Immunity · doi:10.1128/.68.11.6139-6146.2000 · Cited by 398
Miller, S. I., & Mekalanos, J. J. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.5.2485-2490.1990 · Cited by 395
Shafer, W. M., Qu, X.-D., Waring, A. J., & Lehrer, R. I. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.4.1829 · Cited by 391
Experimental evolution of resistance to an antimicrobial peptide
Perron, G. G., Zasloff, M., & Bell, G. (2006) · Proceedings of the Royal Society B: Biological Sciences · doi:10.1098/rspb.2005.3301 · Cited by 369
Ernst, C. M., Staubitz, P., Mishra, N. N., Yang, S.-J., Hornig, G., Kalbacher, H., Bayer, A. S., Kraus, D., & Peschel, A. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000660 · Cited by 368
Patrzykat, A., Friedrich, C. L., Zhang, L., Mendoza, V., & Hancock, R. E. W. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.605-614.2002 · Cited by 354
Lipsky, B. A., Holroyd, K. J., & Zasloff, M. (2008) · Clinical Infectious Diseases · doi:10.1086/593185 · Cited by 324
Guina, T., Yi, E. C., Wang, H., Hackett, M., & Miller, S. I. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.14.4077-4086.2000 · Cited by 322
Abachin, E., Poyart, C., Pellegrini, E., Milohanic, E., Fiedler, F., Berche, P., & Trieu‐Cuot, P. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.02723.x · Cited by 315
Capsule polysaccharide is a bacterial decoy for antimicrobial peptides
Llobet, E., Tomás, J. M., & Bengoechea, J. A. (2008) · Microbiology · doi:10.1099/mic.0.2008/022301-0 · Cited by 312
Bacterial manipulation of innate immunity to promote infection
Diacovich, L., & Gorvel, J.-P. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2295 · Cited by 304
The antimicrobial peptide‐sensing system aps of Staphylococcus aureus
Li, M., Cha, D. J., Lai, Y., Villaruz, A. E., Sturdevant, D. E., & Otto, M. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05986.x · Cited by 297
Cationic Antimicrobial Peptides: Issues for Potential Clinical Use
Bradshaw, J. P. (2003) · BioDrugs · doi:10.2165/00063030-200317040-00002 · Cited by 293
Michalopoulos, A. S., Tsiodras, S., Rellos, K., Mentzelopoulos, S., & Falagas, M. E. (2005) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2004.01043.x · Cited by 292
Antimicrobial Peptide Resistance Mechanisms of Human Bacterial Pathogens
(2006) · Current Issues in Molecular Biology · doi:10.21775/cimb.008.011 · Cited by 289
Paneth cell defensins: Endogenous peptide components of intestinal host defense
Ouellette, A. J., & Selsted, M. E. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.11.8836041 · Cited by 287
Diamond, G., Russell, J. P., & Bevins, C. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.10.5156 · Cited by 268
Resistance to host antimicrobial peptides is necessary for Salmonella virulence.
Groisman, E. A., Parra-Lopez, C., Salcedo, M., Lipps, C. J., & Heffron, F. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.11939 · Cited by 265
Kristian, S. A., Datta, V., Weidenmaier, C., Kansal, R., Fedtke, I., Peschel, A., Gallo, R. L., & Nizet, V. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.19.6719-6725.2005 · Cited by 258
Dissemination of the mcr-1 colistin resistance gene
Zhi, C., Lv, L., Yu, L.-F., Doi, Y., & Liu, J.-H. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00063-3 · Cited by 258
Biological cost and compensatory evolution in fusidic acid‐resistant Staphylococcus aureus
Nagaev, I., Björkman, J., Andersson, D. I., & Hughes, D. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02389.x · Cited by 257
Self-citationAntimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence
Zaiou, M., Nizet, V., & Gallo, R. L. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12132.x · Cited by 256
Human β-Defensin 3 Inhibits Cell Wall Biosynthesis in Staphylococci
Sass, V., Schneider, T., Wilmes, M., Körner, C., Tossi, A., Novikova, N., Shamova, O., & Sahl, H.-G. (2010) · Infection and Immunity · doi:10.1128/iai.00688-09 · Cited by 254
Vitamin D Induces the Antimicrobial Protein hCAP18 in Human Skin
Weber, G., Heilborn, J. D., Chamorro Jimenez, C. I., Hammarsjö, A., Törmä, H., & Ståhle, M. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23687.x · Cited by 253
Use of Antimicrobial Peptides Against Microbial Biofilms: Advantages and Limits
Batoni, G., Maisetta, G., Lisa Brancatisano, F., Esin, S., & Campa, M. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711794088399 · Cited by 252
Expression of β‐defensin 1 and 2 mRNA by human monocytes, macrophages and dendritic cells
Duits, L. A., Ravensbergen, B., Rademaker, M., Hiemstra, P. S., & Nibbering, P. H. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01430.x · Cited by 249
Cationic Antimicrobial Peptide Resistance in Neisseria meningitidis
Tzeng, Y.-L., Ambrose, K. D., Zughaier, S., Zhou, X., Miller, Y. K., Shafer, W. M., & Stephens, D. S. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.15.5387-5396.2005 · Cited by 249
Evolutionary consequences of drug resistance: shared principles across diverse targets and organisms
Hughes, D., & Andersson, D. I. (2015) · Nature Reviews Genetics · doi:10.1038/nrg3922 · Cited by 245
Self-citationNiyonsaba, F., Iwabuchi, K., Matsuda, H., Ogawa, H., & Nagaoka, I. (2002) · International Immunology · doi:10.1093/intimm/14.4.421 · Cited by 241
Resistance Studies with Daptomycin
Silverman, J. A., Oliver, N., Andrew, T., & Li, T. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1799-1802.2001 · Cited by 234
Functional interaction of human neutrophil peptide‐1 with the cell wall precursor lipid II
de Leeuw, E., Li, C., Zeng, P., Li, C., Buin, M. D.-D., Lu, W.-Y., Breukink, E., & Lu, W. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.03.004 · Cited by 222
Stumpe, S., Schmid, R., Stephens, D. L., Georgiou, G., & Bakker, E. P. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.15.4002-4006.1998 · Cited by 214
β-Defensin 1 Contributes to Pulmonary Innate Immunity in Mice
Moser, C., Weiner, D. J., Lysenko, E., Bals, R., Weiser, J. N., & Wilson, J. M. (2002) · Infection and Immunity · doi:10.1128/iai.70.6.3068-3072.2002 · Cited by 213
Antibacterial and Enzymic Basic Proteins from Leukocyte Lysosomes: Separation and Identification
Zeya, H. I., & Spitznagel, J. K. (1963) · Science · doi:10.1126/science.142.3595.1085 · Cited by 210
Thedieck, K., Hain, T., Mohamed, W., Tindall, B. J., Nimtz, M., Chakraborty, T., Wehland, J., & Jänsch, L. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05452.x · Cited by 209
Daptomycin, a Bacterial Lipopeptide Synthesized by a Nonribosomal Machinery
Robbel, L., & Marahiel, M. A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.r110.128181 · Cited by 206
Glycopeptide antibiotic biosynthesis
Yim, G., Thaker, M. N., Koteva, K., & Wright, G. (2014) · The Journal of Antibiotics · doi:10.1038/ja.2013.117 · Cited by 202
Bacterial modification of LPS and resistance to antimicrobial peptides
Gunn, J. S. (2001) · Journal of Endotoxin Research · doi:10.1177/09680519010070011001 · Cited by 191
Roland, K. L., Martin, L. E., Esther, C. R., & Spitznagel, J. K. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.13.4154-4164.1993 · Cited by 191
Gravesen, A., Ramnath, M., Rechinger, K. B., Andersen, N., Jänsch, L., Héchard, Y., Hastings, J. W., & Knøchel, S. (2002) · Microbiology · doi:10.1099/00221287-148-8-2361 · Cited by 190
Yeaman, M. R., Bayer, A. S., Koo, S. P., Foss, W., & Sullam, P. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci562 · Cited by 189
Improved Methods for Classification, Prediction, and Design of Antimicrobial Peptides
Wang, G. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2285-7_3 · Cited by 187
Staphylococcus aureus Small Colony Variants Are Induced by the Endothelial Cell Intracellular Milieu
Vesga, O., Groeschel, M. C., Otten, M. F., Brar, D. W., Vann, J. M., & Proctor, R. A. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/173.3.739 · Cited by 180
Munck, C., Gumpert, H. K., Wallin, A. I. N., Wang, H. H., & Sommer, M. O. A. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009940 · Cited by 178
Lipid Headgroup Discrimination by Antimicrobial Peptide LL-37: Insight into Mechanism of Action
Neville, F., Cahuzac, M., Konovalov, O., Ishitsuka, Y., Lee, K. Y. C., Kuzmenko, I., Kale, G. M., & Gidalevitz, D. (2006) · Biophysical Journal · doi:10.1529/biophysj.105.067595 · Cited by 174
Bengoechea, J. A., & Skurnik, M. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.01956.x · Cited by 169
Poyart, C., Pellegrini, E., Marceau, M., Baptista, M., Jaubert, F., Lamy, M., & Trieu‐Cuot, P. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03655.x · Cited by 165
Molecular engineering approaches to peptide, polyketide and other antibiotics
Baltz, R. H. (2006) · Nature Biotechnology · doi:10.1038/nbt1265 · Cited by 160
Membrane‐Active Small Molecules: Designs Inspired by Antimicrobial Peptides
Ghosh, C., & Haldar, J. (2015) · ChemMedChem · doi:10.1002/cmdc.201500299 · Cited by 159
Cao, M., & Helmann, J. D. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.4.1136-1146.2004 · Cited by 158
Antimicrobial Peptide Resistance Mechanisms of Gram-Positive Bacteria
Nawrocki, K. L., Crispell, E. K., & McBride, S. M. (2014) · Antibiotics · doi:10.3390/antibiotics3040461 · Cited by 157
Yang, S., Bayer, A. S., Mishra, N. N., Meehl, M. A., Ledala, N., Yeaman, M. R., Xiong, Y. Q., & Cheung, A. L. (2011) · Infection and Immunity · doi:10.1128/iai.05669-11 · Cited by 157
Bayer, A. S., Prasad, R., Chandra, J., Koul, A., Smriti, M., Varma, A., Skurray, R. A., Firth, N., Brown, M. H., Koo, S.-P., et al. (2000) · Infection and Immunity · doi:10.1128/iai.68.6.3548-3553.2000 · Cited by 150 · cited 1×
“…membrane fluidity via expression of unsaturated lipids 5 sistan ( 1 7 a l f t m i l t r d T l f b t i s o o a f n d s i 2 r H i g c A a p c b i ( g r 2 s t L m i c i a a e a i i A t i t l 0 D.I. Andersson et al. / Drug Re Bayer et al., 2000) or reducing membrane potential (Yeaman et al., 998).”
BackgroundPhenylbutyrate Induces Antimicrobial Peptide Expression
Steinmann, J., Halldórsson, S., Agerberth, B., & Gudmundsson, G. H. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00818-09 · Cited by 144
Walter, J., Loach, D. M., Alqumber, M. A. A., Rockel, C., Hermann, C., Pfitzenmaier, M., & Tannock, G. W. (2007) · Environmental Microbiology · doi:10.1111/j.1462-2920.2007.01292.x · Cited by 141
Dissemination of the mcr-1 colistin resistance gene
Hu, Y., Liu, F., Lin, I. Y. C., Gao, G. F., & Zhu, B. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00533-2 · Cited by 141
PhoP‐regulated Salmonella resistance to the antimicrobial peptides magainin 2 and polymyxin B
Shi, Y., Cromie, M. J., Hsu, F., TURK, J. W., & Groisman, E. A. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04107.x · Cited by 138
Bacterial resistance to cationic antimicrobial peptides
Anaya-López, J. L., López-Meza, J. E., & Ochoa‐Zarzosa, A. (2012) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2012.699025 · Cited by 127
Therapeutic antimicrobial peptides may compromise natural immunity
Habets, M. G. J. L., & Brockhurst, M. A. (2012) · Biology Letters · doi:10.1098/rsbl.2011.1203 · Cited by 127
Molecular Basis for Prokaryotic Specificity of Magainin-Induced Lysis
Tytler, E. M., Anantharamaiah, G. M., Walker, D. E., et al. (1995) · Biochemistry · doi:10.1021/bi00013a031 · Cited by 126
Genetic Analysis of Colistin Resistance in Salmonella enterica Serovar Typhimurium
Sun, S., Negrea, A., Rhen, M., & Andersson, D. I. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01016-08 · Cited by 125
Self-citationExploiting genomics, genetics and chemistry to combat antibiotic resistance
Hughes, D. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1084 · Cited by 123
Self-citationMolecular Mechanisms of Bacterial Resistance to Antimicrobial Peptides
Kraus, D., & Peschel, A. (2006) · Springer eBooks · doi:10.1007/3-540-29916-5_9 · Cited by 122
The sensor kinase PhoQ mediates virulence in Pseudomonas aeruginosa
Gooderham, W. J., Gellatly, S. L., Sanschagrin, F., McPhee, J. B., Bains, M., Cosseau, C., Lévesque, R. C., & Hancock, R. E. W. (2009) · Microbiology · doi:10.1099/mic.0.024554-0 · Cited by 121
Safety and tolerability of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11)
van der Velden, W. J. F. M., van Iersel, T. M., Blijlevens, N. M. A., & Donnelly, J. P. (2009) · BMC Medicine · doi:10.1186/1741-7015-7-44 · Cited by 119
Identification of the primary antimicrobial domains in human neutrophil cathepsin G.
Bangalore, N., Travis, J. W., Onunka, V. C., Pohl, J., & Shafer, W. M. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77388-2 · Cited by 115
Kaplan, C. W., Sim, J.-H., Shah, K. R., Kolesnikova-Kaplan, A., Shi, W., & Eckert, R. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00342-11 · Cited by 115
Visualizing Attack of Escherichia coli by the Antimicrobial Peptide Human Defensin 5
Chileveru, H. R., Lim, S. A., Chairatana, P., Wommack, A. J., Chiang, I.-L., & Nolan, E. M. (2015) · Biochemistry · doi:10.1021/bi501483q · Cited by 115
Ghosh, A., Kar, R. K., Jana, J., Saha, A., Jana, B., Krishnamoorthy, J., Kumar, D., Ghosh, S., Chatterjee, S., & Bhunia, A. (2014) · ChemMedChem · doi:10.1002/cmdc.201402215 · Cited by 113
Susceptibility of gram-negative bacteria to polymyxin B nonapeptide
Viljanen, P., & Vaara, M. (1984) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.25.6.701 · Cited by 112
Shi, Y., Latifi, T. N., Cromie, M. J., & Groisman, E. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406149200 · Cited by 111
Schmitt, P., Rosa, R. D., & Destoumieux‐Garzón, D. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.10.011 · Cited by 111
Eswarappa, S. M., Panguluri, K. K., Hensel, M., & Chakravortty, D. (2008) · Microbiology · doi:10.1099/mic.0.2007/011114-0 · Cited by 110
Cation-Induced Transcriptional Regulation of the dlt Operon of Staphylococcus aureus
Koprivnjak, T., Mlakar, V., Swanson, L., Fournier, B., Peschel, A., & Weiss, J. P. (2006) · Journal of Bacteriology · doi:10.1128/jb.188.10.3622-3630.2006 · Cited by 108
Lamb, H. M., & Wiseman, L. R. (1998) · Drugs · doi:10.2165/00003495-199856060-00011 · Cited by 108
Thulin, E., Sundqvist, M., & Andersson, D. I. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04819-14 · Cited by 103
Self-citationNilsson, A. C., Janson, H., Wold, H., Fugelli, A., Andersson, K., Håkangård, C., Olsson, P., & Olsen, W. M. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03513-14 · Cited by 103
Kraus, D., Herbert, S., Kristian, S. A., Khosravi, A., Nizet, V., Götz, F., & Peschel, A. (2008) · BMC Microbiology · doi:10.1186/1471-2180-8-85 · Cited by 101
Erickson, K. D., & Detweiler, C. S. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05420.x · Cited by 98
Tamayo, R., Ryan, S. S., McCoy, A. J., & Gunn, J. S. (2002) · Infection and Immunity · doi:10.1128/iai.70.12.6770-6778.2002 · Cited by 94
Samant, S., Hsu, F., Neyfakh, A. A., et al. (2008) · Journal of Bacteriology · doi:10.1128/jb.01345-08 · Cited by 86
Omiganan Pentahydrochloride in the Front Line of Clinical Applications of Antimicrobial Peptides
Melo, M. N., Dugourd, D., & Castanho, M. A. R. B. (2006) · Recent Patents on Anti-Infective Drug Discovery · doi:10.2174/157489106777452638 · Cited by 86
Kupferwasser, L. I., Skurray, R. A., Brown, M. H., Firth, N., Yeaman, M. R., & Bayer, A. S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.10.2395 · Cited by 85
Molecular genetic analysis of the Escherichia coli phoP locus
Groisman, E. A., Heffron, F., & Solomon, F. (1992) · Journal of Bacteriology · doi:10.1128/jb.174.2.486-491.1992 · Cited by 84
Malanović, N., Leber, R., Schmuck, M., Kriechbaum, M., Cordfunke, R. A., Drijfhout, J. W., de Breij, A., Nibbering, P. H., Kolb, D., & Lohner, K. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.07.010 · Cited by 82
Dhawan, V. K., Yeaman, M. R., Cheung, A. L., Kim, E.-S., Sullam, P. M., & Bayer, A. S. (1997) · Infection and Immunity · doi:10.1128/iai.65.8.3293-3299.1997 · Cited by 77
Mechanism and Fitness Costs of PR-39 Resistance in Salmonella enterica Serovar Typhimurium LT2
Pränting, M., Negrea, A., Rhen, M., & Andersson, D. I. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00205-08 · Cited by 76
Self-citationDifferential expression of α‐ and β‐defensins in human peripheral blood
Fang, X., Shu, Q., Chen, Q., Book, M., Sahl, H., Hoeft, A., & Stüber, F. (2003) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.2003.01076.x · Cited by 75
Host-dependent Induction of Transient Antibiotic Resistance: A Prelude to Treatment Failure
Kubicek-Sutherland, J. Z., Heithoff, D. M., Ersoy, S. C., Shimp, W. R., House, J. K., Marth, J. D., Smith, J. W., & Mahan, M. J. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.08.012 · Cited by 72
Self-citationHuang, G. T. ‐., Zhang, H., Kim, D., Liu, L., & Ganz, T. (2002) · Human Gene Therapy · doi:10.1089/10430340260395875 · Cited by 70
Pimecrolimus Enhances TLR2/6-Induced Expression of Antimicrobial Peptides in Keratinocytes
Büchau, A. S., Schauber, J., Hultsch, T., Stuetz, A., & Gallo, R. L. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.135 · Cited by 69
Paulander, W., Maisnier‐Patin, S., & Andersson, D. I. (2007) · Molecular Microbiology · doi:10.1111/j.1365-2958.2007.05713.x · Cited by 68
Self-citationInheritance of Unequal Numbers of the Genes Encoding the Human Neutrophil Defensins HP-1 and HP-3
Mars, W. M., Patmasiriwat, P., Maity, T., Huff, V., Weil, M. M., & Saunders, G. F. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.51.30371 · Cited by 68
Tomenius, H. L., Pränting, M., Thulin, E., & Andersson, D. I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068875 · Cited by 66
Self-citationGarcía‐Quintanilla, M., Carretero-Ledesma, M., Moreno-Martínez, P., Martín-Peña, R., Pachón, J., & McConnell, M. J. (2015) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2015.07.017 · Cited by 62
Phoenix, D. A., Harris, F., Mura, M., & Dennison, S. R. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.02.003 · Cited by 61
Turning Defense into Offense: Defensin Mimetics as Novel Antibiotics Targeting Lipid II
Varney, K. M., Bonvin, A. M. J. J., Pazgier, M., Malin, J. J., Yu, W., Ateh, E. N., Oashi, T., Lu, W., Huang, J., Bruin, M. D.-D., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003732 · Cited by 61
On the in vivo significance of bacterial resistance to antimicrobial peptides
Bauer, M. E., & Shafer, W. M. (2015) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2015.02.012 · Cited by 61
Henderson, J. C., Fage, C. D., Cannon, J. R., Brodbelt, J. S., Keatinge‐Clay, A. T., & Trent, M. S. (2014) · ACS Chemical Biology · doi:10.1021/cb500438x · Cited by 61
Brandis, G., Pietsch, F., Alemayehu, R., & Hughes, D. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku434 · Cited by 60
Self-citationMcLeod, G., & Spector, M. P. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.13.3683-3688.1996 · Cited by 59
Samuelsen, Ø., Haukland, H. H., Kahl, B. C., von Eiff, C., Proctor, R. A., Ulvatne, H., Sandvik, K., & Vorland, L. H. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki385 · Cited by 58
Roland, K. L., Esther, C. R., & Spitznagel, J. K. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.12.3589-3597.1994 · Cited by 56
Gläser, R., Becker, K., von Eiff, C., Meyer‐Hoffert, U., & Harder, J. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.176 · Cited by 56
Induced resistance to the antimicrobial peptide lactoferricin B in Staphylococcus aureus
Samuelsen, Ø., Haukland, H. H., Jenssen, H., Kramer, M. M., Sandvik, K., Ulvatne, H., & Vorland, L. H. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.05.017 · Cited by 48
Human β-Defensin 4 with Non-Native Disulfide Bridges Exhibit Antimicrobial Activity
Sharma, H., & Nagaraj, R. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119525 · Cited by 41
Pränting, M., & Andersson, D. I. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq059 · Cited by 40
Self-citationBerti, A. D., Baines, S. L., Howden, B. P., Sakoulas, G., Nizet, V., Proctor, R. A., & Rose, W. E. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04990-14 · Cited by 34
Strömstedt, A. A., Kristiansen, P. E., Gunasekera, S., Grob, N. M., Skjeldal, L., & Göransson, U. (2016) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2016.02.013 · Cited by 33
Yeaman, M. R., & Bayer, A. S. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-387837-3.00037-7 · Cited by 23
Fitness of Salmonella mutants resistant to antimicrobial peptides
Tomenius, H. L., Anwar, N., Rhen, M., & Andersson, D. I. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku423 · Cited by 19
Self-citationEffect of protamine in obesity induced by high-fat diets in rats
Duarte-Vázquez, M. A., García‐Padilla, S., Olvera-Ochoa, L., González-Romero, K. E., Acosta-Íñiguez, J., la Cruz‐Cordero, R. D., & Rosado, J. L. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.78 · Cited by 16
Hoang, K. V., Wang, Y., & Lin, J. (2012) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2012.00032 · Cited by 13
Cited by
The antimicrobial activity of nanoparticles: present situation and prospects for the future
Wang, L., Hu, C., & Shao, L. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s121956 · Cited by 4,062
Antimicrobial host defence peptides: functions and clinical potential
Mookherjee, N., Anderson, M. A., Haagsman, H. P., & Davidson, D. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0058-8 · Cited by 1,502
Kumar, P., Kizhakkedathu, J., & Straus, S. (2018) · Biomolecules · doi:10.3390/biom8010004 · Cited by 1,227
Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions
Mohammad, S., & Thiemermann, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.594150 · Cited by 585
The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms
de Breij, A., Riool, M., Cordfunke, R. A., Malanovic, N., de Boer, L., Koning, R. I., Ravensbergen, E., Franken, M., van der Heijde, T., Boekema, B. K., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan4044 · Cited by 555
Metadata
- Authors
- Andersson, D. I., Hughes, D., & Kubicek-Sutherland, J. Z.
- Venue
- Drug Resistance Updates
- Publisher
- Elsevier BV
- Published
- 2016-05
- Volume
- 26
- Pages
- 43-57
- ISSN
- 1368-7646 (ISSN-L)
- OpenAlex
- W2342937250
- Cited by
- 715
- References
- 172
- FWCI
- 52.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.